+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Nursing management of MS patients receiving interferon beta-1b therapy

Nursing management of MS patients receiving interferon beta-1b therapy

Rehabilitation Nursing 22(2): 62-6, 81

In 1993, recombinant interferon beta-1b (Betaseron, Berlex Laboratories) was approved by the Food and Drug Administration as a treatment for relapsing-remitting multiple sclerosis (MS). Betaseron is the first therapeutic agent licensed for use with therapeutic patients with MS in more than 20 years. Many patients and their families have expressed great interest in obtaining information about this agent. In response, MS centers throughout the United States have developed Betaseron training programs. This article describes how rehabilitation nurses can educate patients and families about Betaseron.

(PDF emailed within 0-6 h: $19.90)

Accession: 046836744

Download citation: RISBibTeXText

PMID: 9110845

DOI: 10.1002/j.2048-7940.1997.tb01735.x

Related references

Nursing management of patients receiving interferon. Seminars in Oncology Nursing 4(2): 95-101, 1988

Nursing management and support of patients receiving interferon. Medical Clinics of North America Suppl: 47-50, 1986

Nursing management of patients receiving interferon monoclonal antibodies. Journal of Cancer Research & Clinical Oncology 116(SUPPL PART 2): 1050, 1990

Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b. Clinical Journal of Oncology Nursing 2(1): 11-16, 1998

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology 46(1): 12-18, 1996

Neutralizing antibody (NAb) assays in multiple sclerosis patients receiving interferon-beta therapy. Multiple Sclerosis 13(Suppl. 1): S44-S48, 2007

Nursing management of patients receiving biological therapy. Seminars in Oncology Nursing 12(2): 152-162, 1996

Nursing management of patients receiving radiation therapy. Hu Li Za Zhi Journal of Nursing 24(2): 46-50, 1977

Nursing management of patients receiving high-dose IL-2 therapy. Atkins, M B, Mier, J W Basic and Clinical Oncology; Therapeutic applications of interleukin-2: 425-438, 1993

Prevention and management of thrombocytopenia in patients receiving interferon/ribavirin therapy for hepatitis C with recombinant IL-11. Hepatology 32(4 Pt 2): 369A, 2000

Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy. British Journal of Cancer 73(2): 236-240, 1996

Endoscopic management of esophageal varices with band ligation in hepatitis C patients receiving pegylated Interferon/Ribavirin therapy: Safety and success of this approach in three patients. 2007

Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study. Advances in Therapy 35(11): 1894-1904, 2018

The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy. Journal of Pediatric Oncology Nursing 34(3): 160-172, 2017

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. European Cytokine Network 12(1): 56-61, 2001